ICYMI: House Judiciary Subcommittee on Anti-Trust Members Tout Benefits of CREATES Act
Mar 8, 2019
During today’s House Judiciary Subcommittee on Anti-trust hearing on… Read More
© 2026 CSRXP- All Rights Reserved
ICYMI
ICYMI: CSRxP Corrects The Record On Price Transparency
Oct 31, 2018
The Trump Administration took another step earlier this month to help lower… Read More
ICYMI: CSRxP Calls On FDA To Break Down Barriers To Affordable Drugs
Oct 2, 2018
Through the advancement of modern medicine, biologic drugs are providing new… Read More
ICYMI: New poll shows 75% of Americans find Rx prices are just too high.
May 21, 2015
May 21, 2015 Morning Consult: “New Cures, Old Problems: Poll Shows Drug… Read More
ICYMI: “Prescription drug prices climb into the stratosphere”
May 20, 2015
May 20, 2015 “Prescription drug prices climb into the stratosphere”… Read More
ICYMI: New study answers the age old question, “Does R&D really justify high drug costs?” (Spoiler alert: the answer is no.)
May 15, 2015
ICYMI – May 15, 2015 ***** The New England Journal of Medicine: “T… Read More
ICYMI: In anticipation of today’s Cures markup, E&C releases an updated draft while Pew launches a new Rx initiative
May 14, 2015
May 14, 2015 The House Energy and Commerce Committee released an updated… Read More
ICYMI: FDA Advisory Panel Approves New Cystic-Fibrosis Drug while Americans Continue to Pay the Price of High Cost Drugs
May 13, 2015
May 13, 2015 The New York Times: “Cystic Fibrosis Drug Wins Approval of… Read More
ICYMI: “As E&C Prepares Cures Bill Markup, Negative Press On Drug Prices On The Increase”
May 12, 2015
May 12, 2015 InsideHealthPolicy.com Health Reform Insider: “As E&C… Read More
ICYMI: Vertex’s Cystic-Fibrosis Drug Could Come at a Cost
May 11, 2015
May 11, 2015 The Wall Street Journal: “Vertex’s Cystic-Fibrosis… Read More
ICYMI: Should the Specialty Drug Cost Debate Take a Breath? Data Proves Otherwise.
May 7, 2015
ICYMI: May 7, 2015 PharmaExec.com: “Take a Breath” on the Specialty Drug… Read More
ICYMI: Washington’s Role in High Drug Costs — Marketing Exclusivity and “Shadow Pricing”
May 6, 2015
ICYMI: May 6, 2015 National Journal: Washington’s Interest in Precision… Read More